| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| Other Sizes |
|
FR-167653 (FR167653) is a novel and potent p38 MAPK inhibitor with anti-inflammatory activity. It may be used for treating inflammatory diseases, relieving trauma and ischemia-reperfusion injury.
| ln Vivo |
Acute tubular necrosis is considerably lessened by FR 167653 (FR 167653 sulfate) (32 mg/kg; ih; 24-48 hours) [1].
|
|---|---|
| Animal Protocol |
Animal/Disease Models: Inbred male Balbuc mice (8 weeks old) [1]
Doses: 32 kg/mg Route of Administration: subcutaneous injection; 24-48 hrs (hrs (hours)) Experimental Results: 24 hrs (hrs (hours)) and 48 hrs (hrs (hours)) after ischemia-reperfusion, FR- Acute tubular necrosis scores in the cortex and outer medulla of 167653-treated mice were Dramatically lower than those of vehicle-treated mice. |
| References |
|
| Molecular Formula |
C24H18N5O2F.H2O4S
|
|---|---|
| Molecular Weight |
525.5089
|
| Exact Mass |
525.112
|
| CAS # |
158876-66-5
|
| Related CAS # |
FR 167653 free base;158876-65-4
|
| PubChem CID |
135484078
|
| Appearance |
Light yellow to yellow solid powder
|
| Boiling Point |
724.4ºC at 760 mmHg
|
| Flash Point |
391.9ºC
|
| Vapour Pressure |
5.03E-22mmHg at 25°C
|
| LogP |
4.307
|
| Hydrogen Bond Donor Count |
3
|
| Hydrogen Bond Acceptor Count |
10
|
| Rotatable Bond Count |
4
|
| Heavy Atom Count |
37
|
| Complexity |
755
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
KCPHXRBKBLJJJJ-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C24H18FN5O2.H2O4S/c25-19-8-6-17(7-9-19)21-20(16-10-12-26-13-11-16)23-28-30(15-14-29(23)27-21)24(32)22(31)18-4-2-1-3-5-18;1-5(2,3)4/h1-13,28H,14-15H2;(H2,1,2,3,4)
|
| Chemical Name |
1-[7-(4-fluorophenyl)-8-pyridin-4-yl-3,4-dihydro-1H-pyrazolo[5,1-c][1,2,4]triazin-2-yl]-2-phenylethane-1,2-dione;sulfuric acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~100 mg/mL (~190.29 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (4.76 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (4.76 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (4.76 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.9029 mL | 9.5146 mL | 19.0291 mL | |
| 5 mM | 0.3806 mL | 1.9029 mL | 3.8058 mL | |
| 10 mM | 0.1903 mL | 0.9515 mL | 1.9029 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
